(19)
(11) EP 4 135 724 A1

(12)

(43) Date of publication:
22.02.2023 Bulletin 2023/08

(21) Application number: 20722966.7

(22) Date of filing: 15.04.2020
(51) International Patent Classification (IPC): 
A61K 35/17(2015.01)
C12N 5/0783(2010.01)
(52) Cooperative Patent Classification (CPC):
C12N 5/0636; A61K 35/14; A61K 35/15; A61K 35/18; A61K 35/19
 
C-Sets:
  1. A61K 35/19, A61K 2300/00;
  2. A61K 35/18, A61K 2300/00;
  3. A61K 35/15, A61K 2300/00;

(86) International application number:
PCT/US2020/028192
(87) International publication number:
WO 2021/211104 (21.10.2021 Gazette 2021/42)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicant: Amgen Inc.
Thousand Oaks, CA 91320-1799 (US)

(72) Inventors:
  • LIU, Yijun
    Thousand Oaks, California 91320-1799 (US)
  • HENCKELS, Kathryn A.
    Thousand Oaks, California 91320-1799 (US)
  • ARBELAEZ, Carlos
    Thousand Oaks, California 91320-1799 (US)

(74) Representative: Dörries, Hans Ulrich 
df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16
80333 München
80333 München (DE)

   


(54) PROCESS FOR GENERATING GENETICALLY ENGINEERED AUTOLOGOUS T CELLS